Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Immunocore Holdings plc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 139 | 1 | 130 | −8 |
| Shares | 43.1M | 871.8K | 45.3M | +3.05M (+7.2%) |
| Value | $1.46B | $29.5M | $1.41B | −$23.4M (−1.6%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Immunocore Holdings plc at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 873,611 | $27.2M | 0.00% |
| Susquehanna International Group, LLP | 112,199 | $3.49M | 0.01% |
| Schroder Investment Management Group | 65,539 | $2.04M | 0.00% |
| Crossmark Global Holdings, Inc. | 27,803 | $866.0K | 0.02% |
| Verition Fund Management LLC | 23,755 | $739.5K | 0.01% |
| Wolverine Asset Management LLC | 18,922 | $589.0K | 0.01% |
| Group One Trading, L.P. | 18,288 | $569.3K | 0.02% |
| Alpha DNA Investment Management LLC | 13,213 | $411.3K | 0.22% |
| Gsa Capital Partners LLP | 13,039 | $406.0K | 0.03% |
| Bridgefront Capital, LLC | 8,707 | $271.0K | 0.10% |
| HRT Financial LP | 6,479 | $201.0K | 0.00% |
| Simplex Trading, LLC | 871 | $27.0K | 0.00% |
| Acadian Asset Management LLC | 860 | $26.0K | 0.00% |
| Coppell Advisory Solutions LLC | 617 | $19.4K | 0.00% |
| Macroview Investment Management LLC | 269 | $8.37K | 0.01% |
| Wolff Wiese Magana LLC | 94 | $2.93K | 0.00% |
| Elequin Capital LP | 43 | $1.34K | 0.00% |
| J.Safra Asset Management Corp | 5 | $157 | 0.00% |
| Connective Portfolio Management, LLC | 7,000 | – | – |
Sold out (27)
Institutions that held Immunocore Holdings plc at the end of Q2 2024 and filed for Q3 2024 without it.
Not filed for Q3 2024 yet (1)
Institutions that held Immunocore Holdings plc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 871,793 | $29.5M |